Innovate UK

Innovate UK is a non-departmental public body established in 2007 and based in Swindon, United Kingdom. Funded by a government grant, it supports innovation in science and technology by providing funding services to businesses across various sectors and regions. The organization aims to drive productivity and economic growth by facilitating advancements that contribute to the UK’s economic landscape. In addition to funding, Innovate UK offers a range of services and information related to business and economic development, thereby fostering a supportive environment for innovation.

Mike Biddle

Programme Director of Industrial Strategy Challenge Fund

Will Drury

Executive Director, Digital and Technologies

Paul Gadd

Deputy Director

Dr. Tom Jenkins

Deputy Director

Scott James O'Brien

Director, Innovation Finance

Nigel Walker

Deputy Director, Lending and Investor Partnerships

Dave Wilkes

Director of Innovation Ecosystem

Past deals in Europe

MediaCity Immersive Technologies Innovation Hub

Grant in 2025
MediaCity Immersive Technologies is a unique setting with the highest amount of creative, media, mix technology enterprises outside of London.

Diffblue

Grant in 2025
DiffBlue Limited is a developer of artificial intelligence software focused on automating coding tasks, particularly in Java development. Established in 2016 and based in Oxford, United Kingdom, the company specializes in automated testing software that generates unit tests autonomously. DiffBlue's technology leverages reinforcement learning to create fully formed tests that compile and run successfully, addressing one of the most challenging aspects of software development—writing unit tests. In addition to test generation, the company's software aids in bug fixing, refactoring code, translating programming languages, and enhancing security by identifying and rectifying vulnerabilities. DiffBlue's solutions not only save developers time but also provide valuable insights into test coverage, code testability, complexity, dependencies, and code churn, ultimately transforming the software writing process.

Paragraf

Grant in 2025
Paragraf Ltd. is a UK-based company established in 2015, specializing in the development and production of graphene-based electronic devices and materials. The company employs contamination-free technology to create high-purity graphene products, which are designed to enhance the performance of various electronic applications. Paragraf's innovations include devices for green energy generation, such as solar photovoltaic cells, as well as advanced sensors for monitoring environmental and health-related parameters. These products aim to optimize process and quality control across industries including electronics, energy, healthcare, and agriculture. By leveraging graphene's unique properties, Paragraf seeks to significantly impact the electronics industry and contribute to advancements in automation and disease research.

Ayming

Grant in 2025
Ayming is a management consulting firm headquartered in Levallois, France, that focuses on optimizing operational performance for its clients. The company provides a range of services, including consulting on human resources costs, tax strategies, operational costs optimization, software solutions, and energy and environmental issues. Additionally, Ayming offers advisory services related to work contributions and wage audits. By leveraging these diverse consulting offerings, Ayming aims to help organizations enhance their efficiency and overall performance while effectively managing social costs associated with taxes and financial operations.

Tewke

Grant in 2024
Tewke, established in 2020 in London, specializes in developing AI-driven home automation technology to reduce energy consumption and enhance living experiences. The company's flagship product, Tap, is an intelligent light switch that requires no rewiring, serving as the foundation for Tewke's energy control and home automation platform. Tap has been recognized internationally, including winning the Red Dot Design Award.

EcoDuct

Grant in 2024
EcoDuct is a cutting-edge, high-performance non-metallic pre-insulated HVAC ductwork system that saves energy, decreases installation time and costs, minimizes environmental effect, and provides pure, uncontaminated air. EcoDuct is the only pre-insulated ductwork system that comes in a variety of shapes and sizes, including circular, flat oval, square, and rectangular, as well as accessories like FCU plenums and grille boxes, and is built sustainably in the UK using cutting-edge production technology. EcoDuct is appropriate for all indoor and outdoor insulated ducting applications, including new construction, retrofits, and modular structures.

Theolytics

Grant in 2024
Theolytics Limited is a clinical-stage biotechnology company based in Oxford, United Kingdom, specializing in the development of oncolytic viral therapies to combat cancer. Founded in 2017, Theolytics utilizes a phenotypic screening platform that facilitates the discovery and development of effective, targeted therapeutic candidates designed for intravenous delivery. The company's innovative approach is aimed at creating category-changing cancer treatments that can address both solid and liquid tumors. In addition to advancing its internal pipeline of programs, Theolytics is also forming strategic partnerships to enhance and expedite the development of its therapeutic offerings, ultimately striving to provide innovative care options for patients.

Medannex

Grant in 2024
MedAnnex Limited is a biotechnology company based in Edinburgh, United Kingdom, that focuses on developing innovative treatments for patients with autoimmune diseases and cancers. Founded in 2009, the company is dedicated to creating first-in-class antibody therapies, particularly its lead product, annexuzlimab, a monoclonal antibody designed to target and inhibit annexin-A1. This approach aims to modulate both the innate and adaptive immune systems, thereby enhancing treatment options for healthcare providers and improving patient outcomes. Through its specialized research and development efforts, MedAnnex seeks to address significant unmet medical needs in the field of immunotherapy.

Marine Power Systems

Grant in 2024
Marine Power Systems Ltd. is a Swansea-based company focused on developing innovative marine renewable energy technologies. Established in 2008 by engineering graduates from Swansea University, the company specializes in the WaveSub, a wave energy converter designed to harness wave energy for electricity generation. The WaveSub operates underwater, adjusting its depth to optimize energy capture and to withstand severe weather conditions. By utilizing orbital motion with the waves, Marine Power Systems aims to reduce the costs associated with wave energy generation, contributing to the advancement of sustainable energy solutions.

Vector Photonics

Grant in 2024
Vector Photonics, based in Glasgow, Scotland, is a spin-out company from the University of Glasgow. It specializes in developing semiconductor laser technology for data communications and additive manufacturing, including metal and plastic printing. The company's innovation lies in photonic crystal surface-emitting lasers, which are low-cost and emit light from the top surface, facilitating easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies. This enables various industries to adopt their semiconductor laser technology in daily operations.

BiVictrix Therapeutics

Grant in 2024
BiVictriX Therapeutics Ltd. is a drug discovery and development company based in Alderley Edge, United Kingdom, focused on creating bispecific antibody drug conjugates to address unmet medical needs in blood cancer. Established in 2016, the company leverages its proprietary Bi-Cygni technology to develop innovative therapies for various types of cancers, including Acute Myeloid Leukaemia. BiVictriX specializes in oncology and haematological malignancies, offering a range of services that encompass biotherapeutics, immunotherapy, antibody research, and drug development. The company aims to advance its pharmaceutical products through rigorous development processes to improve treatment outcomes for patients with serious medical conditions.

LIfT BioSciences

Grant in 2024
LIfT BioSciences is a biotechnology company based in London, established in 2016, that specializes in advanced innate immuno-cell therapies. It has developed a unique platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT), which enables the production of Immunomodulatory Alpha Neutrophils (IMANs) from induced pluripotent stem cells (iPSCs). This technology aims to address the limitations of existing therapies for solid tumors by utilizing CAR neutrophil cell therapy. The IMANs can alter the tumor microenvironment, enhancing the immune response and enabling a more effective attack on tumors. By leveraging proprietary enhancement media and genetic engineering, LIfT BioSciences seeks to significantly increase the cancer-fighting capabilities of these cells, offering patients the potential for improved outcomes and lasting immunity against cancer.

University of Bristol

Grant in 2024
The University of Bristol is a red brick research university that offers a range of educational courses and services. The university is organized into six academic facilities: Faculty of Arts, Faculty of Engineering, Faculty of Medical and Veterinary Sciences, Faculty of Science, Faculty of Medicine and Dentistry, and Faculty of Social Sciences and Law. These faculties together award a range of academic degrees spanning bachelor's and master's degrees as well as junior doctorates and higher doctorates. University of Bristol was established in 1876 and is based in Bristol, United Kingdom.

GaitQ

Grant in 2024
GaitQ Limited is a medical device company founded in 2019 and based in Oxfordshire, United Kingdom. It specializes in developing the GaitThaw device, which addresses the issue of gait freezing in individuals with Parkinson's disease. This small and portable device employs clinically proven sensory cues to assist patients in re-establishing the connection between the brain and body, thereby facilitating smoother walking. GaitQ aims to improve mobility and enhance the quality of life for those affected by this debilitating symptom of Parkinson's disease.

Fieldwork Robotics

Grant in 2024
Fieldwork Robotics Ltd. is a company based in Plymouth, United Kingdom, that specializes in the development and manufacturing of modular robots for agricultural applications. Founded in 2016, the company focuses on creating commercial robotic tools specifically designed for the efficient harvesting of raspberries. Its innovative technology features a soft, adaptable robotic arm equipped with a highly sensitive gripper, allowing it to handle delicate fruits with care. By utilizing these advanced robotic solutions, Fieldwork Robotics aims to help fruit-growing businesses lower the cost of harvesting per berry, minimize waste, and ensure a more predictable and sustainable harvesting process.

NuKoKo

Grant in 2024
NuKoKo is a manufacturer that specializes in creating cocoa-free chocolate through innovative bean-to-bar processes. The company utilizes ingredients sourced from the UK and has developed patent-pending technology to produce a new type of chocolate that is healthier and more sustainable than traditional options. NuKoKo's products are characterized by low carbon emissions, low sugar content, and high protein levels, allowing consumers to enjoy chocolate while minimizing environmental impact. The focus on healthier, sustainable alternatives positions NuKoKo as a unique player in the chocolate industry, appealing to environmentally conscious consumers.

SolasCure

Grant in 2024
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on advancing treatment options for patients with chronic wounds. Founded in 2017, the company is developing Aurase, a hydrogel designed to enhance wound bed preparation through the application of a recombinant enzyme derived from maggots. This innovative approach aims to facilitate wound debridement, a crucial therapeutic procedure that removes dead, damaged, or infected tissue, thereby accelerating the healing process. By leveraging biomimicry and evidence-based medicine, SolasCure seeks to improve patient outcomes across various healthcare settings.

University of Nottingham

Grant in 2024
The University of Nottingham is a leading, financially secure, campus-based institution renowned for its research, international outlook, and comprehensive academic offerings. It provides undergraduate sport courses and boasts a prestigious business school with campuses in the UK, China, and Malaysia, renowned for its influential research and strong corporate connections. The university is committed to internationalising its core activities, recruiting top students and staff globally, and preparing students for successful futures.

IXICO

Grant in 2024
IXICO plc, established in 1995 and headquartered in London, specializes in providing data analytics services to the global biopharmaceutical industry. The company focuses on the collection, analysis, management, and reporting of data generated during clinical studies, with a particular emphasis on neurological diseases. IXICO's key technologies include Assessa, a digital platform for clinical decision support, and TrialTracker, a comprehensive imaging service workflow management system. The company's end-to-end imaging services are primarily applied in the fields of Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, cerebrovascular, and progressive supranuclear palsy diseases. IXICO's services are utilized to select patients for clinical trials, assess drug safety and efficacy, and for post-marketing surveillance. The company works with pharmaceutical companies, biotech firms, academia, and medical charities worldwide.

Occuity

Grant in 2024
Occuity Ltd is a company focused on the research, design, and manufacture of non-contact optical instruments for healthcare diagnostics and monitoring. Established in 2019 and based in Reading, United Kingdom, Occuity develops a range of handheld optical devices, including pachymeters, pupillometers, and keratometers, which are used in both human and veterinary optometry. These instruments function by projecting light into the eye and analyzing the reflected signals, allowing for direct measurements that assist optometrists and ophthalmologists. Additionally, Occuity's technology facilitates the monitoring of various health conditions, such as diabetes and Alzheimer’s disease, thereby enhancing the effectiveness and accessibility of diagnostic and screening tools in healthcare.

University of Birmingham Endowment

Grant in 2024
The University of Birmingham Endowment is an integral part of the University of Birmingham, based in the United Kingdom. This endowment supports a variety of academic initiatives, including scholarships, professorships, and research programs, which contribute to the university's mission of fostering innovation and advancing knowledge. With a long-standing tradition of excellence, the University of Birmingham is committed to pushing the boundaries of research and education, leveraging its expertise to address contemporary challenges. The endowment's earnings play a crucial role in enabling the university to maintain its reputation for impactful research and academic excellence, ensuring that it continues to develop great minds and influence lives both locally and internationally. The management of the endowment assets is overseen by the council members, who are dedicated to maximizing the fund's contributions to the university's objectives.

Recap

Grant in 2024
Recap is a cryptocurrency accounting platform designed to simplify tax compliance and portfolio management for users engaged in blockchain investments. The platform allows users to connect their accounts, enabling seamless tracking of their cryptocurrency portfolios across various wallets, blockchains, and exchanges. By providing end-to-end encryption and features tailored for tax reporting in the US and UK, Recap helps clients optimize their tax positions and automatically calculate their crypto taxes. This user-friendly and privacy-focused application addresses the complexities of managing numerous transactions, ensuring that users can gain clear insights into their cryptocurrency investments and associated tax obligations.

Dragonfly Insulation

Grant in 2024
Dragonfly Insulation is a spin-out from Newcastle University focused on advancing aerogel manufacturing through an innovative and energy-efficient process. The company specializes in producing synthetic nanostructured porous ceramic products that provide exceptional thermal insulation across various industries, including aerospace, defense, marine, oil and gas, and construction. By simplifying the manufacturing process and reducing energy consumption, Dragonfly Insulation aims to deliver a range of aerogel products that enhance fire safety features and improve overall performance in civil applications.

Optrical

Grant in 2024
Optrical Limited is a company based in Rotherham, United Kingdom, specializing in the development and manufacturing of micro-optic elements. Established in 2016, Optrical focuses on creating advanced optical products that utilize ultra-high and ultra-low refractive index UV materials. The company's primary offerings include Illumax, which provides light extraction and management films for LED and OLED lighting, and Authntrace, which delivers optical anti-counterfeiting and traceability solutions. By leveraging innovative designs and custom manufacturing processes, Optrical aims to enhance the functionality of lighting products and improve product security for various industries.

Ultima Forma

Grant in 2024
Ultima Forma, based in the UK, is a pioneering manufacturer focused on developing advanced metallic engineering components. The company specializes in creating intricate, lightweight, high-strength parts featuring tailored nanoengineered characteristics across multiple materials. Their innovative process enables them to produce complex 3D structures with locally optimized properties, offering versatile solutions for various industries.

Brompton Bicycle

Grant in 2024
Brompton Bicycle is a manufacturer of folding bicycles based in West London, England. The company specializes in producing the Brompton folding bike, which is designed for urban living and commuting. In addition to bicycles, Brompton offers a range of products including electric bikes, bags, clothing, helmets, and various bicycle parts and accessories. The company operates through a network of retail stores and an e-commerce platform, allowing customers to easily access its products. Brompton also provides bike rental services, promoting a sustainable and healthy mode of transportation for city dwellers and visitors alike.

Concr

Grant in 2024
Concr is a techbio company focused on enhancing cancer treatment through innovative predictive modeling. Utilizing methods derived from astrophysics, Concr aims to accurately forecast patient outcomes and responses to both novel and existing cancer therapies. The company's cloud-native platform, FarrSight®, enables researchers to simulate clinical trials, predict therapeutic responses, and conduct bioinformatics analyses, facilitating a more personalized approach to cancer care. By leveraging fragmented data from various stages of drug development, Concr eliminates the reliance on big data while generating precise multi-modal tumor models. Headquartered in London, with a subsidiary in Brisbane, Australia, Concr is backed by prominent investors, including the University of Cambridge Enterprise and Oncology Ventures, among others.

Flock Mobility

Grant in 2024
Flock Mobility, a UK-based B2B cleantech company, specialises in optimising electric vehicle (EV) fleets for shared transport services. Backed by the European Space Agency, Flock's AI-driven platform enhances vehicle utilisation, routing, and booking, empowering operators to reduce emissions, lower costs, and improve mobility access.

CircKit

Seed Round in 2024
CircKit is the AI-driven B2B SaaS platform that empowers fashion & textiles brands to unlock new growth from circular design. Design sustainable products, make smarter material and production choices, measure and track social & environmental indicators, and meet urgent compliance with ease. By harmonising data and enabling collaborative working across teams, CircKit supports brands to reduce costs, increase profit & unlock revenue from circular design and lucrative end-of-life ‘closed loop’ initiatives. CircKit also powers one of the UK's largest sustainable lifestyle marketplaces, as the destination for brands to reach consumers of Fashion and lifestyle products (Beauty, Food & Drink, Home and Wellness)... __________ Veo® is the marketplace for sustainable lifestyle™. Veo took a tech-first approach to build the world's largest and most sustainable online shopping platform. We have solved the scalability problem inherent in large platforms, and created the lifestyle destination for conscious consumers to discover a world of unique, independent, sustainable brands all in one place. We thoroughly assess and vet all our products and brands, we do the research so you don't have to. That's why we've been Ethical Consumer's most ethical retailer for the last 3 consecutive years running and recognised as a global Top 5% Certified B Corporation, with a score of 130.6 and prestigious ‘Best For The World'. We developed our industry-leading assessment matrix which qualifies and approves the full life cycle of products from brands to join the platform. This instils critical consumer trust and assurance for becoming the world's largest, most sustainable lifestyle shopping platform. Our mission is to revolutionise retail, empowering businesses and consumers to embrace circular and regenerative consumption and production (SDG 12). __________ *most sustainable as Ethical Consumer's top-rated 'ethical online retailer' **largest by number of brands & SKUs

Legal Utopia

Grant in 2024
Legal Utopia is a developer of an artificial intelligence platform aimed at enhancing access to legal services. The company focuses on making the law more accessible, affordable, and instantaneous for individuals who may struggle to understand or afford traditional legal assistance. Through its innovative technology, Legal Utopia empowers users to identify their legal issues, comprehend their implications, and explore available options, thereby democratizing access to legal resources. The platform is designed to serve a diverse range of users, ensuring that anyone, regardless of their circumstances or resources, can find support for common legal problems when needed.

Mesenbio

Grant in 2024
Mesenbio is a preclinical biopharmaceutical company based at the University of York, specializing in cell-derived therapies. It has developed a unique technique known as Cell Line Extracellular Vesicle Release (CLEVR), which aims to enhance the treatment pipeline by addressing significant challenges in extracellular vesicle therapy. The company focuses on creating innovative treatments, including a novel therapy for arthritis derived from engineered human stem cells. By unlocking the potential of extracellular vesicles, Mesenbio seeks to transform medical approaches to musculoskeletal diseases, thereby providing more effective therapeutic options.

The University of Edinburgh

Grant in 2023
The University of Edinburgh, established in 1583, is a prestigious institution located in Edinburgh, United Kingdom. It is renowned globally for its academic excellence, offering a wide range of disciplines, including its renowned Medical School and Law School. As one of Scotland's ancient universities, it is committed to delivering high-quality education, conducting cutting-edge research, and fostering innovation to address global challenges.

Nexam Chemical Holding

Grant in 2023
Nexam Chemical Holding is a Sweden-based company specializing in the development and production of advanced solutions that enhance the properties and performance of various polymers. The company manufactures heat-activated cross linkers, which are essential for improving temperature resistance and strength in polymer-based components. These enhancements allow industries to create lighter products, replace more expensive materials, and optimize existing resources. Nexam Chemical serves a diverse range of sectors, including aerospace, electronics, and engineered foams, providing cost-efficient solutions tailored to their needs. Additionally, the company’s technology enables recycled polymers to regain their performance capabilities, contributing to sustainability in the plastics market.

Holly Health

Grant in 2023
Holly Health is a digital health application designed to assist individuals in translating their health intentions into actionable daily practices for improved mental and physical wellbeing. Utilizing proprietary AI technology, the platform provides a personalized and empathetic experience that simulates the guidance of a human health coach. The application has received high ratings for its effectiveness in weight management, stress reduction, wellness, and sleep, earning a commendable score of 89% from ORCHA, a leading health app evaluation organization. Since its international launch in Summer 2021, Holly Health aims to support 5 million users by 2025 and is expanding its presence through partnerships with primary care practices in the UK, having established over 100 collaborations to date. The app features habit reminders, tailored health content, progress tracking, and motivational support, enabling users to prioritize and maintain healthier habits in their daily lives.

Holly Health

Seed Round in 2023
At Holly Health, we are transforming the way individuals approach mental and physical well-being. Founded in 2020, we’ve developed an AI-powered digital health coach that empowers users to turn their health intentions into clear, actionable steps. Our personalized, compassionate service is designed to fit seamlessly into everyday life, supporting long-term, sustainable health changes. Using proprietary AI systems, Holly Health mimics the guidance of a human health coach, offering support in areas such as weight management, stress reduction, wellness, and sleep. We are proud to be ranked among the top 3 health apps by ORCHA, the world’s leading health app evaluation body, with a score of 89%. Since our international launch in 2021, Holly Health has been on a mission to improve the lives of 5 million people by 2025. We are rolling out partnerships with over 100 primary care practices in the UK, helping healthcare professionals support patients with preventative health measures and ongoing well-being. At Holly Health, we believe that health is not a destination but a journey. By offering tailored, science-backed coaching, we make it easier for people to prioritize their well-being every day. Join us as we revolutionize digital health coaching for the modern world.

Holly Health

Seed Round in 2023
Holly Health is a digital health application designed to assist individuals in translating their health intentions into actionable daily practices for improved mental and physical wellbeing. Utilizing proprietary AI technology, the platform provides a personalized and empathetic experience that simulates the guidance of a human health coach. The application has received high ratings for its effectiveness in weight management, stress reduction, wellness, and sleep, earning a commendable score of 89% from ORCHA, a leading health app evaluation organization. Since its international launch in Summer 2021, Holly Health aims to support 5 million users by 2025 and is expanding its presence through partnerships with primary care practices in the UK, having established over 100 collaborations to date. The app features habit reminders, tailored health content, progress tracking, and motivational support, enabling users to prioritize and maintain healthier habits in their daily lives.

Multiverse Computing

Grant in 2023
Multiverse Computing SL is a software development company based in San Sebastian, Spain, with an additional office in Toronto, Canada. Established in 2019, the company specializes in creating quantum computing software that leverages probabilistic and nondeterministic technologies to address complex challenges in various sectors, particularly finance. Multiverse Computing's software solutions are designed for portfolio optimization, risk analysis, and market simulation, enabling clients in industries such as banking, energy, manufacturing, and logistics to harness the power of quantum computing. By focusing on these tailored applications, the company aims to facilitate advancements in solving financial and macro-economic problems, positioning itself as a key player in the emerging quantum technology landscape.

Beta Bugs

Venture Round in 2023
Beta Bugs is an insect genetics company specializing in the development and distribution of high-performance Black Soldier Fly breeds aimed at enhancing productivity in the insect protein sector. The company operates a breeding program called HiPer-Fly® and maintains a dedicated egg production site known as The Multiplier®, supplying its breeds to both UK and international markets. By focusing on biotechnology and breeding techniques, Beta Bugs aims to create a sustainable protein source that can effectively replace traditional feed ingredients such as fishmeal and soymeal in livestock, aquaculture, and pet feed. Headquartered at the Easter Bush Campus, a recognized center for animal genetics, Beta Bugs collaborates closely with the Roslin Institute, noted for its pioneering work in animal genetics.

Brainomix

Grant in 2023
Brainomix Limited is a medical technology company based in Oxford, United Kingdom, that specializes in developing imaging biomarkers and software solutions for neurological and cerebrovascular disorders. Founded in 2010 as a spin-out from the University of Oxford, Brainomix focuses on enhancing clinical decision-making through its AI-powered products. Its flagship offering, e-Stroke, comprises a suite of tools that provide real-time interpretation of brain scans, enabling healthcare professionals to make informed treatment decisions for stroke patients more efficiently. This includes e-ASPECTS, which automates the scoring of brain images to identify early stroke damage, and e-CTA, which standardizes the detection of large vessel occlusions. Additionally, e-Mismatch provides a multi-vendor post-processing solution for MRI and CT scans, enhancing the assessment of stroke damage. By leveraging advanced algorithms and large data analytics, Brainomix aims to improve patient outcomes by ensuring timely and appropriate treatment for stroke patients worldwide.

Pathios Therapeutics

Grant in 2023
Pathios Therapeutics is an early-stage biotech company based in Oxford, United Kingdom, focused on developing therapies for autoimmune diseases and cancer. Founded in 2017, the company specializes in creating small molecule inhibitors that target the pH-sensing G protein-coupled receptor GPR65. These inhibitors are designed to counteract the immunosuppressive effects of immune cells, such as tumor-associated macrophages, which are influenced by the acidic environment often found in tumors. By leveraging a deep scientific approach and human genetic insights, Pathios Therapeutics aims to generate novel therapeutics for advanced solid tumors and other unmet medical needs.

Carbogenics

Seed Round in 2023
Carbogenics Ltd is a company based in Edinburgh, United Kingdom, that specializes in developing sustainable solutions for agriculture and waste management. Founded in 2016, Carbogenics focuses on converting disposable coffee cups and other non-recyclable paper-based waste into plant fertilizer through an innovative low-carbon process. The company produces CreChar, a carbon additive that enhances biogas production and promotes plant growth, ultimately benefiting farmers by improving crop yields and profitability. In addition to its product offerings, Carbogenics provides consultancy and analytical services tailored for anaerobic digestion plant operators, addressing customer inquiries via phone, email, and online applications.

Pensana

Grant in 2023
Pensana is a mineral exploration and development company focused on the supply chain for rare earth metals essential for electric vehicles, wind turbines, and other strategic industries. The company operates primarily in Angola and the UK, with key projects including the Longonjo and Coola Exploration sites. Pensana aims to provide traceable rare earth products while committing to producing the lowest embedded carbon in the market. By leveraging its resources and expertise, the company is positioned to meet the growing demand for sustainable and responsibly sourced rare earth materials.

Stablepharma

Grant in 2023
Stablepharma Ltd is a biotechnology company based in Bath, United Kingdom, focused on developing innovative processes for vaccine stabilization. Its technology platform, StablevaX™, transforms existing approved vaccines, therapeutics, and diagnostics into thermostable products that do not require refrigeration, addressing significant challenges in cold chain logistics. By enabling pre-dosed and stable vaccine delivery, Stablepharma aims to eliminate waste and reduce costs in the distribution of medical products. The company has identified up to 60 vaccine candidates suitable for its technology and collaborates actively with global vaccine manufacturers, academic institutions, and non-governmental organizations to advance its pipeline of thermostable solutions. Established in 2012, Stablepharma is dedicated to improving access to vaccines for children and adults, while also contributing to reduced carbon dioxide emissions in the healthcare sector.

Genie AI

Grant in 2023
Genie AI Limited is a technology company based in London, United Kingdom, that focuses on enhancing the efficiency of legal professionals through its artificial intelligence platform called SuperDrafter. This platform utilizes machine learning to assist lawyers in drafting contracts more quickly and accurately by leveraging the collective knowledge of their firm. In addition to SuperDrafter, the company offers an innovative tool called Anonymiser, which automatically redacts sensitive information from legal documents. Genie AI also organizes educational events that include practical training and discussions on smart contracts, helping legal practitioners navigate the evolving landscape of technology in law. Founded in 2017, Genie AI aims to bridge traditional legal practices with emerging opportunities in blockchain technology.

Kubos Semiconductors

Grant in 2023
Kubos Semiconductors Ltd, established in 2017 and headquartered in Cambridge, United Kingdom, specializes in the development and commercialization of semiconductors. The company focuses on cubic-GaN technology, which is used to produce high-efficiency, low-cost light-emitting diodes (LEDs). Kubos Semiconductors leverages its intellectual property to create wafers for LED manufacturers, aiming to enhance energy savings through advanced semiconductor solutions.

Warwick Business School

Grant in 2023
Warwick Business School (WBS), established in 1967, is located in Coventry, United Kingdom, and is recognized as the UK's leading provider of finance and business education. It aims to become Europe's premier university-based business school by focusing on impactful research and fostering the development of world-class business leaders. WBS offers a diverse range of programs, including undergraduate, master's, MBA, and PhD degrees, attracting students from approximately 120 countries. As the largest department of the University of Warwick, it provides excellent facilities and a prestigious reputation, while striving to deliver a lifelong return on investment for its students, alumni, and partners. The school is committed to advancing management education and producing transformational ideas that deepen the understanding of business and management practices.

Laytrix

Grant in 2023
Laytrix Limited is a company specializing in the development of equipment for laying and removing subsea pipelines. Established in 2017 and based in Darlington, United Kingdom, Laytrix manufactures systems designed to support the offshore industry, particularly in oil and gas, renewables, and marine sectors. Their product offerings include solutions for pipelay and decommissioning, featuring capabilities such as flex lay mode, carbon capture and storage pipelines, and pipeline recovery. Laytrix provides flexible options for clients, including design, build, rental, or licensing of their equipment, enabling efficient and cost-effective operations. Their innovative systems facilitate the rapid installation and demobilization of equipment, allowing clients to optimize resource utilization while minimizing associated risks.

Damibu

Grant in 2023
Damibu Ltd is a technology company specialising in innovative digital solutions, particularly for healthcare and public sector organisations. They focus on creating platforms that simplify content management and distribution, enhancing communication efficiency. Notably, their product Damibu Feeds aids NHS groups in the UK by automating content sharing among GP surgeries, saving time and resources. Their approach emphasises user-friendly designs and interoperability, ensuring seamless integration with existing systems. Damibu's commitment to improving digital health communication is evident in their solutions, which aim to streamline processes, ensure content accuracy, and enhance patient engagement through reliable and accessible information dissemination.

Kalium Health

Grant in 2023
Kalium Health Ltd is a medical technology company based in Cambridge, United Kingdom, that specializes in designing and manufacturing innovative tests for blood potassium concentration. Founded in 2018 and previously known as Kalium Diagnostics Ltd, the company focuses on patient-centric approaches to manage kidney disease, which significantly impacts healthcare costs. Kalium Health is developing a user-friendly finger-prick blood test that allows patients to monitor their potassium levels conveniently and affordably, addressing a critical risk associated with kidney disease. This technology aims to provide real-time, clinically actionable health insights into cardiorenal diseases, thereby transforming the standard of care for millions of patients. With a clear regulatory pathway and a targeted go-to-market strategy, Kalium Health is positioned to make a significant impact in the field of kidney care.

Infleqtion

Grant in 2023
Infleqtion, with offices in the United States, United Kingdom, and Australia, specializes in delivering advanced quantum information solutions tailored to meet critical market needs. Building on 17 years of pioneering research from ColdQuanta, the company develops software-configured, quantum-enabled products that enhance precision and processing power for applications in positioning, navigation, timing, global communication security, and efficiency. Infleqtion's technology serves various sectors, including commercial enterprises and governmental organizations, by providing high-value information streams that facilitate innovation in quantum matter. Its offerings encompass hardware products and AI-powered solutions aimed at advancing resilience in energy distribution and accelerating developments in quantum computing.

New Motion Labs

Debt Financing in 2023
New Motion Labs (NML) is a mechanical engineering intellectual property licensing company based in the United Kingdom. NML specializes in the development and licensing of innovative sprocket tooth profiles designed for sprocket manufacturers. Their proprietary technology, known as Enduo, transforms traditional chain drive systems by facilitating dual point engagement on both sides of the sprocket tooth. This advancement significantly enhances the longevity of conventional chain drives, allowing them to last up to 3.5 times longer and reducing energy losses by 50%. The new tooth profile leads to decreased wear and friction, resulting in a more efficient drivetrain that can be easily retrofitted to existing applications. Through this technology, NML aims to provide users with lightweight and efficient solutions for power transmission.

Cogs

Grant in 2023
Cogs AI is a London-based company founded in 2021 that focuses on providing personalized learning software for students with special educational needs and disabilities. The app is designed to enhance academic outcomes for neurodiverse children by adapting to their individual learning requirements. It generates tailored learning experiences, content, and tasks based on each child's unique cognitive traits, thereby enabling them to reach their full academic potential. Cogs AI aims to create a supportive learning environment that caters specifically to the needs of neurodiverse young people.

Autolomous

Grant in 2023
Autolomous Ltd is a technology company founded in 2019 and based in Mayfair, United Kingdom, that specializes in developing software solutions for cell and gene therapy manufacturers. Its flagship platform, autoloMATE®, is a cloud-native system that offers comprehensive, end-to-end solutions for advanced therapy manufacturing. The platform facilitates the scheduling of patient cell collections, transportation logistics, and tracking of the manufacturing process to ensure compliance with regulatory requirements. Additionally, autoloMATE® supports the management of electronic batch records, provides insights reporting, and oversees review and release activities. The software is designed to be highly configurable, allowing clients to customize workflows to suit their needs. Autolomous emphasizes compliance with regulatory standards and has achieved multiple ISO certifications in areas such as information security, quality management, and environmental management. By leveraging advanced technology and secure data management practices, Autolomous aims to enhance the availability and affordability of autologous medicines for patients.

CGT Catapult

Grant in 2023
CGT Catapult is a UK-based centre of excellence dedicated to advancing the cell and gene therapy sector globally. Supported by Innovate UK, it aims to facilitate the translation of early-stage research into commercially viable therapies. Based in central London with over 120 experts and state-of-the-art laboratories, CGT Catapult offers a comprehensive platform for product development, clinical trials, manufacturing, regulatory support, health economics, and market access expertise. Additionally, they are constructing a £55 million large-scale GMP manufacturing centre to accelerate the delivery of cell and gene therapies to patients worldwide.

Equality Group

Grant in 2023
Equality Group is a consulting organization established in 2018 and based in London, United Kingdom. It specializes in diversifying businesses across finance, technology, and social impact sectors. The firm offers a range of services, including executive search, strategic consultancy, and inclusion education. Additionally, Equality Group has developed Honordex, a data platform that benchmarks and ranks companies based on their equality, diversity, and inclusion (EDI) performance. Through these services and tools, Equality Group aims to enhance organizational effectiveness and promote a more inclusive business environment.

Bridgit Care

Grant in 2023
They care for carers all over the UK with whatever complex needs they may have. They help carers to find carer support resources within their local communities, as well as nationally or with their organisation. All of their solutions deliver to UK addresses, so there is no need for carers and their loved ones to leave the comfort of their own homes to access carer support.

Orthonika

Grant in 2023
Orthonika Limited, founded in 2014 and based in London, United Kingdom, specializes in the development of anatomical meniscus replacement devices, specifically the MenisciKnit. This innovative product addresses the significant clinical gap in treating meniscus injuries, which can lead to debilitating conditions such as osteoarthritis. Traditional treatment methods, including partial meniscectomy and allograft transplantation, have notable limitations, such as incomplete restoration of knee biomechanics and issues related to donor availability and infection risk. Orthonika's MenisciKnit utilizes a unique fiber-reinforced structure embedded in a proprietary polymer, effectively mimicking the natural tissue's properties. This advanced approach aims to restore knee function, helping patients with severe meniscus injuries return to an active lifestyle while fulfilling a critical unmet need in orthopedic care.

i2 media research

Grant in 2023
i2 media research limited is a small interdisciplinary team of experts in how humans and technology can work together – for the benefit of consumers and business. We're the expert consumer insight and user experience research and strategy consultancy based at Goldsmiths University of London, delivering rigorous research and innovation to business. Founded in 2002 as a spin off from Psychology at Goldsmiths, University of London, we are now in our 16th successful year of business. Fully self-funded through commissioned projects and through collaborative research and development projects, i2 media has successfully completed more than 200 commissions, focused on both sides of (and across) the digital divide: from late adopters, to people with very specific access and usability needs, to the earliest adopters of the latest technology and service innovations.

Cineon Immersive Training

Grant in 2023
Cineon Immersive Training, based in Exeter, England, specializes in providing immersive and virtual training services designed for real-world high-risk environments. The company offers a comprehensive suite of training solutions, including instructor-led sessions, e-learning, and virtual reality training, aimed at enhancing participants' skills and safety. In addition to these services, Cineon Immersive Training incorporates eye tracking technology to assess and improve attention, concentration, and cognitive health, thereby delivering a more effective training experience. The company's focus on behavioral training further supports individuals in developing essential skills for various professional settings.

InsideOut

Grant in 2023
InsideOut is a London-based company focused on mental health care and well-being support. It has developed a therapy platform aimed at reducing social stigma surrounding mental health and facilitating open conversations about the subject. The platform provides users with continuous therapy support through an online application that employs an intelligent matching system to connect individuals with the appropriate therapist. This approach enhances users' ability to maintain positive mental well-being by ensuring they receive tailored support based on their specific needs.

Rescape Innovation

Grant in 2023
Rescape Innovation Limited is a healthcare technology company based in Cardiff, United Kingdom, established in 2017. The company specializes in the design and manufacture of healthcare equipment, focusing on virtual reality distraction therapy. Rescape Innovation's technologies aim to address challenges in the healthcare sector, particularly in reducing anxiety and pain for patients while enhancing their overall experience. By leveraging virtual reality, the company seeks to improve communication and management of stress-related issues in clinical settings.

Oxford Dynamics

Grant in 2023
Oxford Dynamics develops robotics & AI solutions for space, security & defence sectors. AVIS (A Very Intelligent System) is OD's flagship generative AI platform for the processing of complex multimodal data. Designed to augment human data analysts, AVIS 'force multiples' their throughput; freeing humans to concentrate on high-level decision-making as opposed to lower-level data sifting and comparison. AVIS is in use by a number of UK government agencies via a Framework Lite Agreement. Oxford Dynamics robotics work includes its STRIDER platform, an AI-enabled tracked robot developed to assist with response to Chemical, Biological, Radiological and Nuclear (CBRN) events. Oxford Dynamics is self-funded via a mix of founders cash, grant and contract wins.

Flybox®

Grant in 2023
Flybox® is an Insect Waste Management (IWM) company delivering innovative insect bioconversion technology and expert support to revolutionise waste management. Flybox® provides tailored IWM solutions for established waste and food businesses, alongside a streamlined breeding and monetisation service that simplifies startup and scaling for new operators. Its modular IWM systems integrate seamlessly with existing waste infrastructure, allowing businesses to transform organic waste streams and byproducts into valuable proteins and fertilisers. With patented technology and a steadfast commitment to circular economy principles, Flybox® is advancing global efforts to reduce landfill dependency, minimise reliance on deforestation-linked soy, and enhance food security. Headquartered in the UK and active internationally, Flybox® is a leader in sustainable waste solutions, driving positive change across agriculture, waste management, and environmental resilience.

RoboK

Grant in 2023
RoboK Limited is a computer vision startup based in Cambridge, United Kingdom, founded in 2017. The company specializes in developing simultaneous localization and mapping (SLAM) algorithms and innovative 3D sensing technologies for various applications, particularly in the automotive and industrial sectors. RoboK aims to enhance safety and performance in industrial workplaces by maximizing the value of existing CCTV systems. Its platform provides a modular and scalable solution for object detection, classification, tracking, and depth estimation, enabling clients to transform passive visual data into actionable insights. The company collaborates with major critical infrastructure operators to optimize their operations through advanced visual analytics.

Vitarka Therapeutics

Grant in 2023
Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Nanovery

Grant in 2023
Nanovery Limited, based in London, United Kingdom, specializes in the development of nanorobots aimed at detecting cancer mutations. Incorporated in 2018, the company leverages advances in nanotechnology, medicinal chemistry, and artificial intelligence to create a platform that enables rapid and sensitive identification of challenging disease biomarkers. These nanorobots are designed to be introduced into blood samples, where they capture circulating tumor DNA and emit a fluorescent signal, facilitating point-of-care detection. This innovative approach not only aids in the early detection of cancer but also enhances the ability to predict the evolution of cancer cells, significantly improving the chances of patient survival. Supported by academic experts, clinicians, and industry leaders, Nanovery is committed to making cancer detection more efficient and accessible.

QV Bioelectronics

Grant in 2023
QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to enhance life expectancy for patients suffering from glioblastoma, a brain tumor known for its poor prognosis and limited treatment options. Recognizing the significant gaps in effective therapies, co-founder Dr. Richard Fu, an academic neurosurgeon, teamed up with biomedical engineer Dr. Chris Bullock to address design flaws in existing electric field therapies. Their solution leverages advanced materials science, including the use of graphene, to optimize device performance and patient outcomes. Since its inception, QV Bioelectronics has garnered nearly $1 million in funding from various UK institutions and over $1 million from international life science investors. The company operates from its research hub in Alderley Park, Cheshire, and boasts a multidisciplinary team with extensive experience in bringing innovative medical devices to the clinic.

CLUBZERØ

Grant in 2023
CLUBZERØ is an innovative company focused on tackling the global issue of packaging waste through its AI-powered zero waste packaging system. It offers a scalable and cost-effective alternative to single-use packaging for various sectors, including food and beverage brands, asset managers, and cities. CLUBZERØ provides a comprehensive service that encompasses packaging, drop points, washing, and logistics, making it up to 30% cheaper than traditional single-use options. Unlike compostable alternatives, which can contribute to environmental harm, CLUBZERØ's approach promotes true zero waste through a circular model, enabling brands to achieve up to a 93% reduction in CO2 emissions. Its AI technology allows for interoperability among diverse packaging types, addressing customer needs effectively. Having launched in the UK and US, CLUBZERØ has successfully processed over 1.3 million orders and helped save millions of single-use items from landfills. The company has collaborated with major brands and received several prestigious awards for its contributions to sustainable packaging, aiming to transform the returnable packaging sector with its advanced systems.

Productive Machines

Grant in 2023
Productive Machines is a company that specializes in software optimization services for the machining industry, focusing on enhancing productivity and sustainability for manufacturers. By leveraging a digital twin of the machining process, which simulates the physics, mechanics, dynamics, distortion, and vibration involved in metal cutting, Productive Machines enables manufacturers to test millions of parameters in a virtual environment. This innovative approach allows for improved Computer-Aided Manufacturing (CAM) and Gcode, effectively eliminating chatter vibrations, reducing cycle times, minimizing tooling costs, and enhancing surface finish and dimensional accuracy. As a spin-out from the UK Advanced Manufacturing Research Centre, Productive Machines aims to streamline machining processes, empowering companies to achieve higher quality parts more efficiently and cost-effectively.

Multus

Grant in 2023
Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Brainspark Games

Grant in 2023
Brainspark Games is an educational technology company that develops mobile games. Their focus is on creating free, culturally inclusive, and AI-powered augmented reality games that align with the UK's national curriculum. The company's platform combines technology and gamification to make learning fun and engaging for children, ensuring accurate and culturally nuanced content. Brainspark Games aims to create an "eduverse" of educational mobile games, promoting inclusive and equitable learning.

Brainspark Games

Grant in 2023
Brainspark Games is an educational technology company that develops mobile games. Their focus is on creating free, culturally inclusive, and AI-powered augmented reality games that align with the UK's national curriculum. The company's platform combines technology and gamification to make learning fun and engaging for children, ensuring accurate and culturally nuanced content. Brainspark Games aims to create an "eduverse" of educational mobile games, promoting inclusive and equitable learning.

Brainspark Games

Grant in 2022
Brainspark Games is an educational technology company that develops mobile games. Their focus is on creating free, culturally inclusive, and AI-powered augmented reality games that align with the UK's national curriculum. The company's platform combines technology and gamification to make learning fun and engaging for children, ensuring accurate and culturally nuanced content. Brainspark Games aims to create an "eduverse" of educational mobile games, promoting inclusive and equitable learning.

Healthera

Debt Financing in 2022
Healthera Ltd., established in 2015 and headquartered in Cambridge, UK, specializes in developing digital health solutions. Its flagship product, Healthera, is a pharmacy-integrated medication management app that offers automatic prescription reminders, smart labelling, scheduling, health condition tracking, and professional advice from pharmacists. Additionally, Healthera operates a healthcare marketplace that connects patients with local pharmacies and GPs, enabling faster medicine delivery and personalized care. The company partners with over 1000 pharmacies and Clinical Commissioning Groups (CCGs) across the UK, reaching over 20 million people. Healthera's technology is accredited by NHS Digital and aims to improve prescribing efficiency, patient experience, and reduce wastage within the NHS.

WeWALK

Grant in 2022
WeWALK Limited is a London-based company established in 2017 that develops innovative mobility tools for visually impaired individuals. The company is best known for its smart cane, which incorporates advanced technology, including an ultrasonic sensor that detects obstacles above chest height and provides haptic feedback to enhance navigation safety. Additionally, the WeWALK mobile application complements the smart cane by offering features such as outdoor navigation, wayfinding, integration with Amazon Alexa, and public transportation enhancements. By merging cutting-edge technology with personal experience, WeWALK aims to foster greater independence and social inclusion for visually impaired people, transforming their mobility experience and empowering them in their daily lives.

Vann

Grant in 2022
Vann is a platform for people affected by cancer aiming to help millions of people globally and revolutionize cancer research and care. Vann has been backed by the Oxford University Innovation, Innovate UK, OxLEP European Regional Development Fund, and UK angel investors and is based in the UK.

iEthico

Grant in 2022
iEthico is a technology company that specializes in streamlining the sourcing of medicines through its innovative digital platform. The company's automated cloud-based service tracks essential data and provides critical intelligence, alerting users to shortages and connecting them with reliable sources. iEthico's platform is approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and features an automated regulatory process that eliminates paperwork, saving pharmacies significant time and effort. Following successful market testing, iEthico's solution is being rolled out to community pharmacies and NHS Trusts across the UK. The company aims to empower pharmacists by delivering insights that help mitigate the impact of medicine shortages, enabling distributors and providers to navigate multiple suppliers efficiently, reduce costs, and supply medicines across various geographies.

OutThink

Seed Round in 2022
OutThink is a London-based cybersecurity startup recognized by Gartner and Forrester for its innovative approach to transforming how companies engage with their employees to educate them about cyber risks and change behaviors. The company's award-winning SaaS platform is designed to identify and reduce risky workforce behaviors, helping organizations build a risk-aware culture. OutThink's solution, developed by Chief Information Security Officers (CISOs) for CISOs, addresses the growing demand for fully trained employees in combating cyber threats. The platform quantifies human risk and dynamically allocates awareness learning content based on employees' security behaviors and attitudes, thereby improving productivity and cybersecurity learning engagement while reducing employee risk and ensuring regulatory compliance.

LabGenius

Grant in 2022
LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Acurable

Grant in 2022
Acurable Limited is a MedTech company based in London, specializing in the development and commercialization of a wearable sensor-based health care device aimed at diagnosing and managing respiratory conditions. Founded in 2016, Acurable has created the AcuPebble, a device that enables non-invasive diagnosis of sleep apnea and other respiratory issues through the collection and analysis of acoustic signals. The AcuPebble employs advanced algorithms to extract clinically relevant parameters and biomarkers, facilitating automated and accurate diagnosis while significantly reducing the risk of misdiagnosis. This innovative technology, the result of a decade of research at Imperial College London, allows for home use without the need for specialist training or hospital visits, thereby lowering overall healthcare costs. Acurable's mission is to enhance understanding of human biosignals to ensure that no one dies from a treatable condition.

Adamo Foods

Grant in 2022
Adamo Foods is a UK-based food technology company specializing in the development of plant-based whole-cut meats. Utilizing proprietary fermentation technology alongside mycelium, the company produces sustainable steak and other meat alternatives. Adamo Foods aims to provide functional meat proteins through precision fermentation, offering consumers an efficient, sustainable, and ethical food option that does not compromise on taste or experience.

Aegiq

Grant in 2022
Aegiq Ltd. is a company specializing in the development of semiconductor-based quantum photonic chips, which are designed for various communications and computing applications such as broadband quantum communication, imaging, microscopy, and scalable quantum computing. Founded in 2019 and headquartered in Sheffield, United Kingdom, Aegiq adopts a full-stack photonic quantum computing approach that provides speed, compactness, and modularity. The company's technology serves a diverse range of industries, including defense, aerospace, cybersecurity, and artificial intelligence, addressing complex computational challenges. Aegiq's integrated photonic platform aims to facilitate large-scale quantum computing with multi-million qubit operations, offering a comprehensive portfolio of products and systems related to quantum cybersecurity and networking.

Stemnovate

Grant in 2022
Stemnovate Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative tools and technologies for drug screening and safety testing. Established in 2016, the company offers a range of products including induced pluripotent stem cells, primary human and multispecies cells, and a comprehensive cell culture and analysis package. Stemnovate employs advanced devices such as micro physiological systems and microfluidic technologies to facilitate research and development. One of its notable projects, the "Liver on chip," focuses on liver toxicity testing and integrates cellular reprogramming, stem cell research, and organ-on-chip technology. The company also provides services in cell reprogramming, differentiation, and application development, catering to a diverse clientele that includes pharmacists, contract research organizations, small to medium enterprises, and academic institutions.

Paragraf

Grant in 2022
Paragraf Ltd. is a UK-based company established in 2015, specializing in the development and production of graphene-based electronic devices and materials. The company employs contamination-free technology to create high-purity graphene products, which are designed to enhance the performance of various electronic applications. Paragraf's innovations include devices for green energy generation, such as solar photovoltaic cells, as well as advanced sensors for monitoring environmental and health-related parameters. These products aim to optimize process and quality control across industries including electronics, energy, healthcare, and agriculture. By leveraging graphene's unique properties, Paragraf seeks to significantly impact the electronics industry and contribute to advancements in automation and disease research.

Better Nature

Grant in 2022
Better Nature Ltd. is a UK-based company specializing in the production of organic plant-based protein products. Founded in 2018 and located in Chesterfield, the company primarily offers a range of tempeh products, including tempeh mince, tempeh rashers, smoked tempeh, and lupin tempeh. These products are designed to provide nutrition for vegan diets, leveraging the benefits of tempeh, which is created through the fermentation of cooked soybeans. This process yields a protein-rich, gluten-free food that is also high in prebiotics and fiber. Better Nature distributes its offerings through an online platform, making its products accessible to a wide audience.

Biotangents

Debt Financing in 2022
Biotangents Ltd. is a biotechnology company based in Glasgow, United Kingdom, specializing in the design and construction of biological pathways to produce desirable natural materials. Founded in 2015, Biotangents utilizes its proprietary Leapfrog Assembly platform to create complex genetic constructs from multiple DNA components. The company has developed notable technologies such as Short Sequence Randomisation and Moduleic Sensing, the latter of which focuses on modular cell-free nucleic acid detection. Biotangents is also engaged in creating a veterinary diagnostic device aimed at detecting various infectious diseases in livestock. This device utilizes isothermal amplification technology, allowing for precise molecular detection without extensive technical requirements, and can be swiftly adapted to target new pathogens. Through its innovations, Biotangents strives to mitigate the impact of infectious diseases in livestock, enabling more efficient production of animal protein.

Veolia UK

Grant in 2022
Veolia UK is a prominent provider of environmental solutions, focusing on the management of water, waste, and energy. The company delivers a wide range of services, including water treatment, sustainable water management, wastewater reuse, waste sorting, and collection. Operating as part of a global group with a significant workforce, Veolia UK supports various sectors, including industrial, commercial, healthcare, and municipal organizations. Its commitment to sustainability aims to enhance resource access, preserve existing resources, and promote their replenishment. Veolia UK plays a vital role in contributing to the sustainable development of communities and industries throughout the region.

Stok.ly

Grant in 2022
Stok.ly Ltd is a software development company based in Hereford, United Kingdom, founded in 2015. The company specializes in creating a multi-channel retail software solution tailored for small to medium-sized retailers. Stok.ly's platform allows users to manage their business operations across various e-commerce channels, including integration with their own websites, social media, and online marketplaces. The software encompasses features such as stock control, ePOS, inventory management, and website development, all accessible through a single cloud-based dashboard. This user-friendly solution enables retailers to operate their businesses efficiently without the burden of contracts or upfront fees, facilitating growth in sales while reducing operational costs.

Earth Rover

Grant in 2022
Earth Rover Limited is a company based in Newport, United Kingdom, that specializes in developing robotic agriculture systems aimed at enhancing farming efficiency. Founded in 2017, the company designs autonomous farming robots that utilize advanced technology derived from the ExoMars Rover. These robots are equipped with precision tools for various agricultural applications, including scouting, weeding, and selective harvesting. By integrating these systems with an intelligent data platform, Earth Rover enables farmers to transition from traditional farming methods to more advanced, autonomous practices, promoting the production of fresh and chemical-free products.

Puraffinity

Grant in 2022
Puraffinity Ltd., established in London in 2015, specialises in innovative water treatment solutions. The company designs and develops precision materials, notably a sustainable adsorbent capable of removing challenging pollutants like pesticides, pharmaceuticals, and PFAS from contaminated water and wastewater. Utilising advanced supramolecular chemistry methods, Puraffinity's technology binds target chemicals selectively, enabling clients to meet stringent regulations and protect local ecosystems sustainably.

Paranimo

Venture Round in 2022
Paranimo is a mental healthcare technology company dedicated to enhancing workplace mental health support. By utilizing advanced matching intelligence, Paranimo offers a suite of software-as-a-service (SaaS) and consulting solutions designed for human resources managers. The company's platform facilitates connections between clients and therapists across the United Kingdom, allowing therapists to identify and rank mental health conditions and determine compatibility with potential clients. This approach not only promotes mental health awareness but also enables individuals to access therapy sessions conveniently, helping them feel better faster. Through its innovative technology, Paranimo aims to democratize access to essential mental health resources in the workplace.

Brainspark Games

Grant in 2022
Brainspark Games is an educational technology company that develops mobile games. Their focus is on creating free, culturally inclusive, and AI-powered augmented reality games that align with the UK's national curriculum. The company's platform combines technology and gamification to make learning fun and engaging for children, ensuring accurate and culturally nuanced content. Brainspark Games aims to create an "eduverse" of educational mobile games, promoting inclusive and equitable learning.

Xampla

Grant in 2022
Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, focused on developing and producing plant protein-based materials as sustainable alternatives to conventional plastics. Founded in 2018, Xampla specializes in creating biodegradable and biocompatible products, including microcapsules, beads, films, threads, and various other structures made entirely from pea protein. These materials are designed for diverse commercial applications, spanning sectors such as food, cosmetics, household products, animal feed, packaging, and medical uses. By eliminating synthetic ingredients and reducing reliance on polluting plastics, Xampla aims to provide environmentally friendly solutions that align with the growing demand for sustainable materials in the marketplace.

ev.energy

Grant in 2022
Ev.energy is a London-based company founded in 2018 that specializes in smart charging software for electric vehicles. The company develops an energy intelligence platform designed to optimize the charging process, making it both environmentally friendly and cost-effective for utility providers and their customers. By wirelessly connecting to various electric vehicles and Level 2 chargers, Ev.energy intelligently manages the charging of these vehicles in accordance with utility and network signals. This approach not only helps to reduce carbon emissions but also engages customers through a mobile application that rewards them for their participation. Through its innovative solutions, Ev.energy aims to facilitate affordable and sustainable electric vehicle charging for drivers at home.

Drone Ag

Grant in 2022
Drone Ag is a UK-based company focused on enhancing agricultural productivity through drone automation and artificial intelligence software. Comprising a team of farmers, agronomists, drone pilots, and software engineers, the company leverages its extensive experience from operating drone systems on its own 6,000-acre farm. Drone Ag develops practical software solutions and provides training courses for farmers and agronomy companies. Its technology includes systems that collect and analyze leaf-level crop data, allowing farmers to optimize the use of ground machinery and drone sprayers by targeting specific areas of fields at the right times. This approach not only helps in efficient crop assessment but also promotes precision agriculture, ensuring that farmers can enhance their operations effectively.

Brainspark Games

Grant in 2022
Brainspark Games is an educational technology company that develops mobile games. Their focus is on creating free, culturally inclusive, and AI-powered augmented reality games that align with the UK's national curriculum. The company's platform combines technology and gamification to make learning fun and engaging for children, ensuring accurate and culturally nuanced content. Brainspark Games aims to create an "eduverse" of educational mobile games, promoting inclusive and equitable learning.

Sixfold Bioscience

Grant in 2021
Sixfold Bioscience Inc. is a London-based company founded in 2018 that specializes in the development of innovative drug delivery techniques aimed at treating cancer patients. The company focuses on engineering programmable oligonucleotide delivery systems that are designed to deliver RNA specifically to diseased cells. This targeted approach enhances the efficacy of treatments while minimizing side effects, positioning Sixfold Bioscience at the forefront of advancements in cancer therapy.

SETsquared Partnership

Grant in 2021
SETsquared Partnership is a collaborative initiative established in 2001, based in Southampton, United Kingdom. It brings together the universities of Bath, Bristol, Exeter, Southampton, and Surrey to foster the growth of high-tech startups and new business ventures. The organization specializes in enterprise activities, including business incubation, spin-outs, and licensing. SETsquared provides comprehensive support to startups through mentoring, access to investors and industry experts, and tailored training programs. Additionally, it engages in research collaboration and consultancy with various industries, enhancing the innovation ecosystem in the region.

University of Surrey

Grant in 2021
The University of Surrey, situated in Guildford just 30 miles from London, has a rich history dating back to 1891. It focuses on addressing global challenges through innovative research and education. The university is committed to nurturing students' curiosity and fostering a desire to contribute positively to society. With a beautiful campus environment, Surrey emphasizes the importance of research and development, aiming to enhance the quality of life and advance knowledge across various fields.

Addionics

Grant in 2021
Addionics Limited is a company focused on designing and developing advanced rechargeable batteries, primarily for electric vehicles. Founded in 2017 and headquartered in London, with an additional office in Tel-Aviv, Israel, Addionics specializes in innovative battery architecture that enhances energy density, reduces charging times, and improves thermal safety. The company utilizes a unique 3D battery architecture to minimize internal resistance and enhance mechanical longevity, thereby significantly improving overall battery performance. By transforming the physical structure of batteries at a microscopic level, Addionics aims to revolutionize energy storage and delivery, supporting battery manufacturers and automakers in producing safer, more efficient, and cost-effective energy solutions. The company's efforts are geared towards accelerating the development and scalability of its proprietary technology, contributing to a more sustainable future.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.